LTFS
ANIK icon

Ladenburg Thalmann Financial Services’s Anika Therapeutics ANIK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$14K Buy
272
+203
+294% +$11.8K ﹤0.01% 4309
2019
Q3 		$4K Buy
+69
New +$3.54K ﹤0.01% 4746
2019
Q2 		– Sell
-180
Closed -$5K – 5257
2019
Q1 		$5K Sell
180
-75
-29% -$2.57K ﹤0.01% 4632
2018
Q4 		$9K Sell
255
-262
-51% -$9.46K ﹤0.01% 4316
2018
Q3 		$22K Sell
517
-483
-48% -$19.1K ﹤0.01% 3841
2018
Q2 		$50K Hold
1,000
– – ﹤0.01% 3239
2018
Q1 		$50K Sell
1,000
-2,819
-74% -$159K ﹤0.01% 3239
2017
Q4 		$206K Sell
3,819
-2,375
-38% -$131K ﹤0.01% 2196
2017
Q3 		$359K Buy
6,194
+4,993
+416% +$261K ﹤0.01% 1676
2017
Q2 		$59K Sell
1,201
-14
-1% -$645 ﹤0.01% 2906
2017
Q1 		$53K Sell
1,215
-2,597
-68% -$124K ﹤0.01% 2857
2016
Q4 		$187K Buy
3,812
+2,432
+176% +$112K ﹤0.01% 1865
2016
Q3 		$66K Sell
1,380
-4,076
-75% -$201K ﹤0.01% 2566
2016
Q2 		$293K Buy
5,456
+80
+1% +$3.77K ﹤0.01% 1428
2016
Q1 		$240K Buy
5,376
+4,420
+462% +$179K ﹤0.01% 1484
2015
Q4 		$37K Buy
956
+106
+12% +$4.05K ﹤0.01% 2786
2015
Q3 		$28K Hold
850
– – ﹤0.01% 2869
2015
Q2 		$28K Buy
850
+50
+6% +$1.78K ﹤0.01% 3002
2015
Q1 		$33K Hold
800
– – ﹤0.01% 2856
2014
Q4 		$32K Sell
800
-3,400
-81% -$133K ﹤0.01% 2658
2014
Q3 		$154K Sell
4,200
-1,600
-28% -$69.1K ﹤0.01% 1357
2014
Q2 		$269K Hold
5,800
– – 0.01% 1044
2014
Q1 		$238K Hold
5,800
– – 0.01% 1044
2013
Q4 		$221K Buy
5,800
+5,050
+673% +$156K 0.01% 1028
2013
Q3 		$18K Buy
+750
New +$16.8K ﹤0.01% 2512

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ANIK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Anika Therapeutics (ANIK) stake by 294% in Q4 2019, buying an estimated $11.8K and bringing the position to 272 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4309.

Ladenburg Thalmann Financial Services first reported a position in ANIK in Q3 2013 and has held it in 25 quarters since. The position peaked at $359K in Q3 2017. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 272 shares of Anika Therapeutics worth $14K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 203 Anika Therapeutics shares in Q4 2019, an estimated $11.8K.
  • Anika Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4309 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Anika Therapeutics in Q3 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's Anika Therapeutics position peaked at $359K in Q3 2017.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.